Vaccine characterization solutions

Immunize the world: Realize a future of safe, stable and life-changing vaccines – made possible with our world-leading tools.

Our collaboration with Malvern Panalytical will help us to work even better on our ongoing and future projects to achieve stability improvements for a range of vaccines

Dr. Andreas Seidl, Chief Operating Officer at Leukocare

What’s stopping your vaccine from changing the world?

Innovation in vaccine development and production is moving at speed. However, developing novel vaccines is uniquely challenging.  

Do you recognize these challenges?  

  • Staying ahead of the competition, especially when 3rd generation vaccines receive ever-higher levels of investment
  • Implementing appropriate methods and analytical tools to create consistent, safe and efficacious vaccine products 
  • Staying compliant with constantly evolving, ceaselessly changing regulatory guidelines
  • Finding the efficiencies, people, and resources to develop innovative products and processes 
  • Successfully transferring new discoveries to scale-up and manufacturing
  • Keeping up to date with the latest technology and approaches 

mRNA vaccines

A new era in vaccinology 

Less than a year after the SARS-CoV-2 virus was initially identified and sequenced, the US FDA granted emergency use authorization to Moderna and Pfizer/BioNTech for their mRNA vaccines, a new platform for humans. 

The mRNA vaccine delivers a nucleoside modified messenger RNA (mRNA), and the human host cell machinery uses this mRNA as a template to produce CoV S proteins. After the 1st and 2nd vaccine doses, the host learns how to make antibodies specifically against the S proteins. 

If we are then infected with SARS CoV-2 virus, our immune system rapidly mobilizes and we are very likely to avoid serious illness, hospitalization and death from COVID-19.

The use of mRNA has several beneficial features over conventional and advanced vaccine platforms such as subunit, killed and live attenuated virus, and DNA-based vaccines.

Read the blog

Join the immunization revolution

Malvern Panalytical provides more than just analytical instruments. 

Whatever approach you are taking to vaccine development, we can help you implement the characterization tools and know-how you need to bring your life-changing vaccines to the world.  

From material characterization to vaccine manufacturing and quality control – we can help you overcome your challenges: 

  • Our experienced scientists can act as a flexible extension to your team – if you’re facing a challenge with your program then chances are, our team has faced it before
  • Once we’ve identified the right methods, we provide development services to overcome your specific challenges in the most efficient way
  • Our approach bridges the physicochemical characterization, expertise, bandwidth or technology gaps in your organization. 
  • Our physicochemical characterization solutions have applications across numerous stages of vaccine development, from fundamental research to manufacturing and production 
  • We help you develop reliable, repeatable techniques that improve the efficiency of your workflows (without you having to break a sweat)
  • Access training and support to upskill your team and quickly realize the full value of your investment in the analytical technology


Are you ready to combine next-level analytical tools with decades-long experience to help drive forward the next wave of vaccine products? 

Watch the webinar seriesSpeak to an expert
Focus on Vaccine DevelopmentGot a question about a vaccine development challenge you’re facing? Speak to an expert today.

Watch the webinars 

Speak to an expert 

Featured product: MicroCal DSC range

636585346795159006KA.jpg

Speed up your thermal stability studies via the gold standard analytical tool for biotherapeutics, biological macromolecules and polymers in solution

Find out more 

Want to know more? Take a look at our tools and resources to support your vaccine development:

Thermal stability

Find out more 


Sample homogeneity

Find out more 


Viral titer

Find out more 


Colloidal stability

Find out more 


Particle concentration

Find out more 


Recombinant protein candidate selection and stability prediction

Find out more 


Adjuvant selection and suitability

Find out more 


Polysaccharide composition

Find out more 


Got a question?

Contact us 

Thermal stability

Differential Scanning Calorimetry (DSC) enables understanding and monitoring of the higher-order structure (HOS) and thermal stability of proteins at every stage of virus-based vaccine development, and during process development for recombinant products. DSC is also used to understand the thermal stability of liposomes used as carriers in nucleic acid-based vaccines.

Featured products and content

MicroCal DSC range

The "Gold Standard" for structural stability analysis of biotherapeutics, b...
MicroCal DSC range

Sample homogeneity

Dynamic Light Scattering and laser diffraction have wide-ranging application for the measurement of particle size and size distribution, to detect the presence of aggregates and ensure sample homogeneity in the development of vaccines of all types.

Featured products and content

Mastersizer 3000

Delivering the data you need for outcomes you can trust
Mastersizer 3000

Spraytec

Spray particle and spray droplet size measurement
Spraytec

Viral titer

Depending on the particle size involved, Multi-Angle Dynamic Light Scattering and Nanoparticle Tracking Analysis are used to measure viral titer throughout the development lifecycle for virus-based vaccines.

NanoSight range

Visually track size and count nanoparticles
NanoSight range

Colloidal stability

Electrophoretic light scattering is used in the characterization and formulation development of products such as mRNA vaccines that use virus-like particles (VLPs), liposomes and other nanoparticles as carriers, to determine size and colloidal stability.

Particle concentration

Particle concentration is critical when using carriers such as VLPs, liposomes and other nanoparticles. Nanoparticle Tracking Analysis and Multi-Angle Dynamic Light Scattering are used to measure particle concentration during characterization and formulation development stages. 

NanoSight range

Visually track size and count nanoparticles
NanoSight range

Recombinant protein candidate selection and stability prediction

Differential Scanning Calorimetry is a fundamental tool for characterizing proteins and plays a key role in the understanding of protein stability under various conditions. Dynamic Light Scattering is used to investigate and predict protein stability and to provide stability-indicating data that is used throughout development.

MicroCal DSC range

The "Gold Standard" for structural stability analysis of biotherapeutics, b...
MicroCal DSC range

Adjuvant selection and suitability

Many vaccines require the presence of an adjuvant in the formulation to ensure an effective immune response. Depending on the vaccine type, Electrophoretic Light Scattering, laser diffraction, Nanoparticle Tracking Analysis and Differential Scanning Calorimetry all have roles in optimizing formulation with adjuvants. 

Polysaccharide composition

Size Exclusion Chromatography with advanced detection aids in the compositional analysis of the protein and polysaccharide content of polysaccharide-conjugate vaccines during process development and manufacturing. 

OMNISEC

The world’s most advanced multi-detector GPC/SEC system
OMNISEC

Are you ready to develop world-changing vaccines?

To find out how our team of experts can accelerate the development of your next product and speed up your journey to market, contact us today.